A common mutation in the KRAS gene is associated with improved overall survival in pancreatic ductal adenocarcinoma (PDAC) compared with other variants, in part because the mutation appears to lead to less invasiveness and weaker biological activity, according to a multicenter study conducted at Weill Cornell Medicine, NewYork-Presbyterian,

Computational Approach Yields Novel Cancer Targets
September 6, 2024
Researchers at Weill Cornell Medicine have used artificial intelligence to identify drug targets based on mapping regulatory networks in patient tumors. The study, published Sept.

Do Clonal Hematopoiesis and Mosaic Chromosomal Alterations Increase Solid Tumor Risk?
September 6, 2024
Repurposed from Medscape on Friday, September 5, 2024
Do Clonal Hematopoiesis and Mosaic Chromosomal Alterations Increase Solid Tumor Risk?
Clonal hematopoiesis of indeterminate potential (CHIP) and mosaic chromosomal alterations (mCAs) are associated with an increased risk for breast cancer, and CHIP is associated with increased mortality in patients with colon cancer, according to the authors of new research.



How a novel genomic analysis leveraged whole-exome and RNA sequencing to save the life of an elderly patient
July 16, 2024
An 81-year-old former minor league baseball player with a history of cancer arrived at the emergency department with a fractured forearm and leg pain after a fall at home.

Welcome to the Inaugural 'Bridge 2AI' Voice Summer School Class!
July 11, 2024
The EIPM is thrilled to welcome the inaugural 'Bridge 2AI' Voice Summer School Class!
The project Voice as a Biomarker of Health is one of several recently funded projects of the NIH Common Fund’s Bridge2AI program, which is designed to use AI to tackle complex biomedical challenges.


EIPM's Second Quarter External Newsletter
July 1, 2024
Dear Friend of the Englander Institute for Precision Medicine,
Welcome to our second quarterly external newsletter of 2024!

The Sounds of Science
June 24, 2024
Sound as Biomarker
Dr. Anaïs Rameau is the granddaughter of a poet who lost his voice to cancer. Though he died when she was young, that spiritual connection steered Dr. Rameau into otolaryngology, where she now helps patients with difficulty speaking, swallowing or breathing.